In vivo γ-aminobutyric acid increase as a biomarker of the epileptogenic zone: An unbiased metabolomics approach.
- DOI
- 10.1111/epi.16768
- Published
- 2021 Jan
- Container
- Epilepsia
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/epi.16768,
title = {In vivo γ-aminobutyric acid increase as a biomarker of the epileptogenic zone: An unbiased metabolomics approach.},
author = {Hamelin S and Stupar V and Mazière L and Guo J and Labriji W and Liu C and Bretagnolle L and Parrot S and Barbier EL and Depaulis A and Fauvelle F},
year = {2021},
journal = {Epilepsia},
doi = {10.1111/epi.16768},
url = {https://doi.org/10.1111/epi.16768}
}RIS
TY - JOUR TI - In vivo γ-aminobutyric acid increase as a biomarker of the epileptogenic zone: An unbiased metabolomics approach. AU - Hamelin S AU - Stupar V AU - Mazière L AU - Guo J AU - Labriji W AU - Liu C AU - Bretagnolle L AU - Parrot S AU - Barbier EL AU - Depaulis A AU - Fauvelle F PY - 2021 JO - Epilepsia DO - 10.1111/epi.16768 UR - https://doi.org/10.1111/epi.16768 ER -
APA
S, H., V, S., L, M., J, G., W, L., C, L., L, B., S, P., EL, B., A, D., & F, F. (2021). In vivo γ-aminobutyric acid increase as a biomarker of the epileptogenic zone: An unbiased metabolomics approach.. Epilepsia. https://doi.org/10.1111/epi.16768
Source records
- pubmed · retrieved 2026-09-27T16:44:16.769Z
- europe-pmc · retrieved 2026-09-27T16:44:16.780Z
- hal · retrieved 2026-09-27T16:44:16.799Z